World of DTC Marketing

AUGUST 16, 2021

SUMMARY: President Biden wants to lower prescription drug costs. Healthcare costs in the US are out of control. Even though prescription drug costs are only $.11 11 of every healthcare dollar spent, drug companies are an easy target to help reduce costs. It is coming a lot faster now, and pharma has to be ready.

Prescription 180

Prescription Media Pharma Healthcare 180

World of DTC Marketing

OCTOBER 27, 2020

We keep hearing the term “consumers of health” but the American healthcare system is too profitable to allow people to be consumers of healthcare. What if … people got a fair ROI for healthcare spending the way we expect a reasonable return from other investments? Except in healthcare. Shopping for healthcare?

Healthcare 230

Healthcare Healthcare Insurance Retail 230

Pharmaceutical Technology

DECEMBER 2, 2022

These results have important implications for the pharmaceutical industry and US healthcare sector over the next two years. If he is re-elected, his second term could bring back the healthcare policies and agendas seen in his first term, such as reduced spending for both Medicare and Medicaid.

Pharma 59

Pharma Government Healthcare Healthcare 59

World of DTC Marketing

MARCH 23, 2021

The media, rather than focus on the real driver of high healthcare costs, loves to point the finger at big pharma. percent of total health-care spending—in 2016, the last year for which there are definitive data. The drug industry has had a large target on its back for a long time.

Distribution 187

Distribution Prescription FDA Pharma 187

pharmaphorum

JANUARY 9, 2023

In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 89

Medicine Healthcare Healthcare Pharma 89

pharmaphorum

JANUARY 29, 2023

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. Secondly, pressure on healthcare spending is leading to greater consolidation.

Healthcare 92

Healthcare Healthcare Manufacturing Marketing 92

PM360

JUNE 29, 2022

Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. Prescription refills can now be placed with a simple click on a patient portal. Prescription refills can now be placed with a simple click on a patient portal.

Retail 97

Retail Healthcare Healthcare Marketing 97

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. 2 The percentage of healthcare providers willing to see pharmaceutical company reps in person had declined from 67% in 2018 to 54% in 2019. Fierce Healthcare. THE CHALLENGE.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

Doctors 57

Doctors Medicine Marketing Prescription 57

Clarify Health

DECEMBER 13, 2022

Life sciences and healthcare are becoming united. Clapsis spoke about the role CVS Health is playing in capturing and using RWD for clinical research: “What’s really exciting now is that we have the ability to generate patient reported outcomes (PROs) and other observational data as part of the normal course of healthcare.

Recruitment 52

Recruitment Retail Patients Education 52

Clarify Health

DECEMBER 13, 2022

Life sciences and healthcare are becoming united. Clapsis spoke about the role CVS Health is playing in capturing and using RWD for clinical research: “What’s really exciting now is that we have the ability to generate patient reported outcomes (PROs) and other observational data as part of the normal course of healthcare.

Recruitment 52

Recruitment Retail Patients Education 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US.

Marketing 104

Marketing Physicians Competition Patients 104